DE69521500D1 - Phosphorsäurediester-derivate - Google Patents
Phosphorsäurediester-derivateInfo
- Publication number
- DE69521500D1 DE69521500D1 DE69521500T DE69521500T DE69521500D1 DE 69521500 D1 DE69521500 D1 DE 69521500D1 DE 69521500 T DE69521500 T DE 69521500T DE 69521500 T DE69521500 T DE 69521500T DE 69521500 D1 DE69521500 D1 DE 69521500D1
- Authority
- DE
- Germany
- Prior art keywords
- group
- alkyl group
- phenyl
- alkoxy
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003013 phosphoric acid derivatives Chemical class 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000003277 amino group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- -1 phenylsulfonylamino group Chemical group 0.000 abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 150000005690 diesters Chemical class 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65128—Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3736194 | 1994-03-08 | ||
| JP12652694 | 1994-06-08 | ||
| JP25148494 | 1994-09-19 | ||
| PCT/JP1995/000303 WO1995024410A1 (fr) | 1994-03-08 | 1995-02-27 | Derive de diester phosphonique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69521500D1 true DE69521500D1 (de) | 2001-08-02 |
| DE69521500T2 DE69521500T2 (de) | 2001-12-13 |
Family
ID=27289441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69521500T Expired - Fee Related DE69521500T2 (de) | 1994-03-08 | 1995-02-27 | Phosphorsäurediester-derivate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5798344A (de) |
| EP (1) | EP0749974B1 (de) |
| KR (1) | KR100233703B1 (de) |
| CN (1) | CN1066739C (de) |
| AT (1) | ATE202567T1 (de) |
| AU (1) | AU679344B2 (de) |
| CA (1) | CA2184891C (de) |
| DE (1) | DE69521500T2 (de) |
| WO (1) | WO1995024410A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702701D0 (en) * | 1997-02-01 | 1997-04-02 | Univ Newcastle Ventures Ltd | Quinazolinone compounds |
| WO2000029414A1 (fr) * | 1998-11-18 | 2000-05-25 | Viktor Veniaminovich Tets | Dialkyl-1-aryl-1-(2,4-dioxo-5-amino-1,3-pyrimidin-5-yl)methylphosphonates |
| US6890930B1 (en) | 1999-09-28 | 2005-05-10 | 3-Dimensional Pharmaceuticals, Inc. | Quinazolinones |
| KR20020047186A (ko) * | 1999-09-28 | 2002-06-21 | 플레믹 크리스티안 | 퀴나졸리논 |
| US20060229324A1 (en) * | 2002-10-03 | 2006-10-12 | Akiko Itai | Quinazolin-4-one derivatives |
| EP1608317B1 (de) | 2003-03-25 | 2012-09-26 | Takeda Pharmaceutical Company Limited | Dipeptidylpeptidase-hemmer |
| JP2007511467A (ja) | 2003-05-14 | 2007-05-10 | タケダ サン ディエゴ インコーポレイテッド | ジペプチジルペプチダーゼインヒビター |
| US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7579357B2 (en) * | 2003-08-13 | 2009-08-25 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| JP2007505121A (ja) | 2003-09-08 | 2007-03-08 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
| US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| CN102127057A (zh) | 2004-03-15 | 2011-07-20 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| US7259155B2 (en) * | 2004-05-05 | 2007-08-21 | Otsuka Pharmaceutical Factory, Inc. | Phosphonic diester derivatives |
| EP1753730A1 (de) | 2004-06-04 | 2007-02-21 | Takeda Pharmaceutical Company Limited | Dipeptidylpeptidasehemmer |
| WO2006019965A2 (en) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| EP2332527A3 (de) * | 2004-10-20 | 2011-11-16 | Resverlogix Corp. | Flavanoide und Isoflavanoide für die Prävention und Behandlung von kardiovaskulären Erkrankungen |
| JP2008524331A (ja) * | 2004-12-21 | 2008-07-10 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼ阻害剤 |
| ZA200802857B (en) | 2005-09-14 | 2009-09-30 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
| KR101368988B1 (ko) | 2005-09-16 | 2014-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 디펩티딜 펩티다제 억제제 |
| WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| AR062760A1 (es) * | 2006-09-13 | 2008-12-03 | Takeda Pharmaceutical | Administracion de inhibidores de dipeptidilpetidasa |
| TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| PL2118074T3 (pl) | 2007-02-01 | 2014-06-30 | Resverlogix Corp | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| NZ586440A (en) | 2008-06-26 | 2011-07-29 | Resverlogix Corp | Methods of preparing quinazolinone derivatives |
| ES2463097T3 (es) * | 2009-01-08 | 2014-05-27 | Resverlogix Corp. | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
| US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
| NZ596117A (en) | 2009-04-22 | 2014-10-31 | Resverlogix Corp | Novel anti-inflammatory agents |
| HUE044986T2 (hu) | 2011-11-01 | 2019-11-28 | Resverlogix Corp | Orális, azonnali felszabadulású készítmények szubsztituált kinazolinonokhoz |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| KR20150096794A (ko) | 2012-12-21 | 2015-08-25 | 제니쓰 에피제네틱스 코포레이션 | 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물 |
| CN114984016A (zh) | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05504969A (ja) * | 1990-02-13 | 1993-07-29 | メルク・エンド・カムパニー・インコーポレーテツド | 置換ベンジル要素を含有するアンギオテンシン２アンタゴニスト類 |
| JP2696150B2 (ja) * | 1991-02-05 | 1998-01-14 | 株式会社大塚製薬工場 | キノリン誘導体 |
| US5624918A (en) * | 1993-06-17 | 1997-04-29 | Otsuka Pharmaceutical Factory, Inc. | Phosphonic diester derivatives |
-
1995
- 1995-02-27 CA CA002184891A patent/CA2184891C/en not_active Expired - Fee Related
- 1995-02-27 EP EP95909996A patent/EP0749974B1/de not_active Expired - Lifetime
- 1995-02-27 KR KR1019960704953A patent/KR100233703B1/ko not_active IP Right Cessation
- 1995-02-27 DE DE69521500T patent/DE69521500T2/de not_active Expired - Fee Related
- 1995-02-27 AT AT95909996T patent/ATE202567T1/de not_active IP Right Cessation
- 1995-02-27 CN CN95192824A patent/CN1066739C/zh not_active Expired - Fee Related
- 1995-02-27 WO PCT/JP1995/000303 patent/WO1995024410A1/ja active IP Right Grant
- 1995-02-27 AU AU18244/95A patent/AU679344B2/en not_active Ceased
- 1995-02-27 US US08/704,740 patent/US5798344A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1147257A (zh) | 1997-04-09 |
| AU1824495A (en) | 1995-09-25 |
| WO1995024410A1 (fr) | 1995-09-14 |
| CN1066739C (zh) | 2001-06-06 |
| KR970701722A (ko) | 1997-04-12 |
| EP0749974A1 (de) | 1996-12-27 |
| CA2184891C (en) | 2000-09-26 |
| ATE202567T1 (de) | 2001-07-15 |
| US5798344A (en) | 1998-08-25 |
| KR100233703B1 (ko) | 1999-12-01 |
| CA2184891A1 (en) | 1995-09-14 |
| EP0749974B1 (de) | 2001-06-27 |
| AU679344B2 (en) | 1997-06-26 |
| EP0749974A4 (de) | 1997-12-17 |
| DE69521500T2 (de) | 2001-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69521500D1 (de) | Phosphorsäurediester-derivate | |
| DE69927516D1 (de) | Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und fungizide für landwirtschaft/gartenbau | |
| NO1995008I1 (no) | Spirapril | |
| FI965020A (fi) | Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita | |
| DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
| DE69530706D1 (de) | Huperzin-derivate, ihre herstellung und ihre verwendung | |
| ATE141508T1 (de) | Zusammensetzung zur förderung des lipidmetabolismus | |
| DE69529619T2 (de) | Pyrimidinylpyrazolderivate | |
| DE69934027D1 (de) | 2-(n-cyanimino)thiazolidin-4-on derivate | |
| DE69734952D1 (de) | Anilide als ACAT-Hemmer | |
| ES2089041T5 (es) | Compuestos de piridinasulfonamida sustituida, composiciones herbicidas que los contienen, y procedimiento para su preparacion. | |
| DE69612967D1 (en) | Optisch aktive thiazolidinonderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |